CD8A and cancer: KIR2DL2/L3/S2+ CD8+ T lymphocytes exhibited over-expression of genes that are not usually expressed in CD8+ T cells, i.e., EGFR, ITGB1, MAP2K1, and CD86, indicating that these cells are reprogrammed to the AKT/PI3K cancer pathway.